与代谢功能障碍相关的脂肪性肝病:COPD的新兴并发症
Ali Al Dailaty1,2, Ahmad Ghanem2, Ghaydaa Abou Daher1,2
1Department of Internal Medicine, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon.
Therapeutic advances in chronic disease
|September 30, 2025
概括
与代谢功能障碍相关的脂肪性肝病 (MASLD) 经常与慢性阻塞性肺病 (COPD) 共同存在. 了解它们的共同机制和临床影响对于综合护理和向治疗至关重要.
科学领域:
- 肺病学和肝病学 肺病学和肝病学
- 内部医学 内部医学
- 心脏代谢疾病 心脏代谢疾病
背景情况:
- 慢性阻塞性肺病 (COPD) 和与代谢功能障碍相关的脂肪性肝病 (MASLD) 是普遍存在的,通常是并发性疾病.
- MASLD是全球慢性肝病的首要原因,影响高达25%的人口,在COPD患者中越来越多的认可.
- 共同的风险因素包括心脏代谢问题,慢性炎症和脂质损伤链接COPD和MASLD的病理生理学.
研究的目的:
- 审查COPD患者中MASLD的流行病学.
- 探索COPD和MASLD之间的共享病理生理机制.
- 在COPD的背景下讨论MASLD的临床影响,诊断策略和管理.
主要方法:
- 文献综述侧重于流行病学数据.
- 分析共享的机械路径.
- 综合当前的诊断和管理方法.
主要成果:
- 在COPD患者中,MASLD是显著的并发症.
- 共享的心脏代谢风险因素,炎症和脂质代谢是关键联系.
- 综合护理和风险分层可以通过承认这种并发症来改善.
结论:
- MASLD是COPD的一种临床相关的并发症.
- 需要对机械相互作用和双向影响进行进一步的研究.
- 认识到MASLD可以提高COPD患者的护理和治疗策略.
相关概念视频
COPD: Pathogenesis and Clinical Features
1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Chronic Obstructive Pulmonary Disease
2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
Overview of Lipid Metabolism
4.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.8K


